AU1748697A - Hepatitis pretreatment composition and method - Google Patents

Hepatitis pretreatment composition and method

Info

Publication number
AU1748697A
AU1748697A AU17486/97A AU1748697A AU1748697A AU 1748697 A AU1748697 A AU 1748697A AU 17486/97 A AU17486/97 A AU 17486/97A AU 1748697 A AU1748697 A AU 1748697A AU 1748697 A AU1748697 A AU 1748697A
Authority
AU
Australia
Prior art keywords
hepatitis
pretreatment composition
pretreatment
composition
hepatitis pretreatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17486/97A
Inventor
Elliot Alpert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU1748697A publication Critical patent/AU1748697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
AU17486/97A 1996-01-19 1997-01-16 Hepatitis pretreatment composition and method Abandoned AU1748697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1022496P 1996-01-19 1996-01-19
US010224 1996-01-19
PCT/US1997/000664 WO1997025862A1 (en) 1996-01-19 1997-01-16 Hepatitis pretreatment composition and method

Publications (1)

Publication Number Publication Date
AU1748697A true AU1748697A (en) 1997-08-11

Family

ID=21744627

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17486/97A Abandoned AU1748697A (en) 1996-01-19 1997-01-16 Hepatitis pretreatment composition and method

Country Status (2)

Country Link
AU (1) AU1748697A (en)
WO (1) WO1997025862A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
FR2769505B1 (en) * 1997-10-10 2000-06-30 Michael Gerard Tovey COMPOSITIONS OF CYTOKINES FOR ADMINISTRATION TO THE ORAL MUCOSA, AND USES THEREOF
AU1399100A (en) * 1998-12-02 2000-06-19 Pharma Pacific Pty Ltd Therapeutic treatment with immunogenic drugs
US7587329B2 (en) 2000-06-02 2009-09-08 Drason Consulting Services, Llc Method and system for optimizing employee scheduling in a patient care environment
US7457765B2 (en) 2000-06-02 2008-11-25 Drason Consulting Services, Llc Method and system for scheduling employees in a patient care environment
WO2004000266A1 (en) * 2002-06-20 2003-12-31 Yuriy Vasilievich Tyagotin Method for oral transmucosal delivery of interferon

Also Published As

Publication number Publication date
WO1997025862A1 (en) 1997-07-24

Similar Documents

Publication Publication Date Title
AU2591697A (en) Oil-sorbing article and methods for making and using same
AU1752697A (en) Deicing composition and method
AU4261697A (en) Compounds and methods
AUPO976797A0 (en) Method and composition (III)
GB2298713B (en) Method and composition
AUPO976597A0 (en) Method and composition (I)
AU6368394A (en) Polymer-polypeptide composition and method
AU7050098A (en) Drilling method and system using foam - foaming composition
AU3200197A (en) New composition and methods
AU1748697A (en) Hepatitis pretreatment composition and method
AUPN137895A0 (en) Composition and method
AU7364598A (en) Coating composition and method
GB2318356B (en) Composition and method
AU5594794A (en) Immunotherapy composition and method
AU3646797A (en) Composition and method to remove asbestos
GB9408342D0 (en) Method and composition
AU3646897A (en) Composition and method to remove asbestos
GB9414888D0 (en) Method and composition
GB9419087D0 (en) Method and composition
AU4130897A (en) Pesticidal composition and method
AU4101197A (en) Labelling method and components therefor
AUPO144096A0 (en) Composition and process
AU7974094A (en) Anti-acne method and composition
GB9308051D0 (en) Method and composition
GB9603856D0 (en) Composition and method